Cargando…
Stopping guidelines for an effectiveness trial: what should the protocol specify?
BACKGROUND: Despite long-standing problems in decisions to stop clinical trials, stopping guidelines are often vague or unspecified in the trial protocol. Clear, well-conceived guidelines are especially important to assist the data monitoring committees for effectiveness trials. MAIN TEXT: To specif...
Autores principales: | Tyson, Jon E., Pedroza, Claudia, Wallace, Dennis, D’Angio, Carl, Bell, Edward F., Das, Abhik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862046/ https://www.ncbi.nlm.nih.gov/pubmed/27165260 http://dx.doi.org/10.1186/s13063-016-1367-4 |
Ejemplares similares
-
Advantages of Bayesian monitoring methods in deciding whether and when to stop a clinical trial: an example of a neonatal cooling trial
por: Pedroza, Claudia, et al.
Publicado: (2016) -
The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
por: Russell, Jill, et al.
Publicado: (2020) -
What you hear and see specifies the perception of a limb-respiratory-vocal act
por: Pouw, Wim, et al.
Publicado: (2022) -
Humidification Practices of Extremely Preterm Neonates: A Clinical Survey
por: Rizk, Nina, et al.
Publicado: (2022) -
What should be the core outcomes in chronic pain clinical trials?
por: Turk, Dennis C, et al.
Publicado: (2004)